Coronavirus and SARS-CoV-2
Coronavirus disease (COVID-19) is a new infection and virulent respiratory disease occurs when virus-containing particles expired by an infected person, either respiratory droplets or aerosols effectuated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an uncommon severe acute respiratory syndrome coronavirus. Although SARS-CoV-2 has a response for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyper inflammation. The virus predominantly spreads between people through close contact and by means of respiratory droplets induced from coughs or sneezes and it mainly enters human cells by binding to the receptor angiotensin converting enzyme 2.
Most common symptoms are:
- Fever
- Dry cough
- Tiredness
Related Conference of Coronavirus and SARS-CoV-2
Coronavirus and SARS-CoV-2 Conference Speakers
Recommended Sessions
- Immune Disorders
- Allergic Contact Dermatitis
- Allergic Rhinitis
- Allergy and Inflammation
- Anaphylaxis and Asthma
- Autoimmune Diseases
- Cancer Immunology
- Clinical Immunology
- Coronavirus and SARS-CoV-2
- Developmental Immunology
- Food Allergy and Drug Allergy
- Immune System and Allergic Reactions
- Immunopathology of COVID 19
- Immunotherapy and Behavioural Immunity
- Market and Future of Therapeutics
- Molecular Allergology and Allergy Diagnostics
- Neonatal and Pediatric Immunology
- Oral Allergy Syndrome
- Oral Immunotherapy and Allergen Immunotherapy
- Vaccination and Immunisation
- Veterinary Allergology
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)
